In-person CPD Event |
Baker McKenzie Sydney office
Tower One - International Towers Sydney
Level 46, 100 Barangaroo Avenue | Sydney NSW 2000 | Australia
Overview (Program Summary)
A program hosted by:
ACC AustraliaDoors open: 4:00pm
Session: 4:30-5:45pm AEST
Drinks, canapes and networking opportunities between 5:45–7:00pm
Australia’s healthcare landscape is undergoing rapid transformation - driven by digital innovation, evolving patient expectations, and a renewed emphasis on accessibility and integrated healthcare.
From telehealth and eScripts, multi-jurisdictional supply chains, new and innovative pharmacy models, and care-in-the-home patient services, the boundaries of traditional care delivery are dissolving. Legal and compliance professionals in the healthcare and life sciences industries are uniquely positioned to address these challenges and opportunities.
This exclusive in-person event is designed for in-house counsel navigating the dynamic landscape and complexities of the healthcare sector and will feature an interactive Q&A panel discussion with industry experts.
Key topics will include:
• Legal exposure and regulatory fragmentation in cross-jurisdictional care
• Data privacy, cybersecurity, and AI governance in connected health
• Regulation of emerging patient care delivery platforms and services
As legal professionals, your role in advocating for change, supporting new initiatives and emerging technologies is vital. This forum will foster a broader discussion beyond legal risks, enabling in-house lawyers to contribute value and take a leadership role in the ongoing transformation of healthcare delivery in Australia.
Speakers
Jessica Kanevsky, Legal Director, AbbVie, Australia and New Zealand
Jessica Kanevsky is a seasoned legal professional with over 20 years of experience.
As the Legal Director for AbbVie Australia and New Zealand, she specialises in delivering strategic legal guidance and since joining AbbVie in December 2014, has played a pivotal role in providing innovative and practical solutions to complex legal challenges, ensuring compliance while enabling business growth.
In February 2024, Jess was appointed to the AbbVie Australia Affiliate Management Team (AMT), reflecting her integral role and leadership within the organisation. Her expertise draws from a robust background that includes private practice and a tenure at another leading pharmaceutical company.
Jess holds a Bachelor of Law and Commerce from Macquarie University and a Master of Law from the University of Sydney, underscoring her strong academic foundation in the legal field.
Jess grew up in Sydney and has always lived close to the beach. She spends her weekends around a netball court, either watching her daughters play or playing netball herself.
Michelle Gregory, Country Head of Public Affairs, Novartis, Australia & New Zealand
Michelle is the Country Head of Public Affairs at Novartis, Australia & New Zealand. Novartis is globally recognised as one of the leading pharmaceutical companies and has been at the forefront of commercialising innovative medicines, including cell and gene therapies and radiopharmaceuticals, across the globe.
Michelle has an extensive background working in Government, including as a Senior Policy Advisor to a former NSW Premier, with lead responsibility for the health and education portfolios. She has qualifications in Law (Juris Doctor) from UNSW and International and Global Studies (BA) from the University of Sydney.
Dr Matthew Vickers, Specialist GP and Clinical Director, Eucalyptus
Dr Matthew Vickers is a specialist GP and Clinical Director at Eucalyptus. Dr Matt is a practicing GP and GP supervisor, working in family medical practice for over nine years since leaving the hospital system. He is passionate about improving primary care outcomes for patients, especially how the use of digital health technologies can enable this. He is a strong advocate for improving clinical governance and safety in health-tech organisations, including through improved interoperability, patient-centred care and clinician leadership.
Sidney Kung, Special Counsel, Baker McKenzie Sydney
Sidney is a Special Counsel in Baker McKenzie's Sydney office and is part of the Firm’s Intellectual Property and Technology, and Healthcare and Life Sciences Groups.
Sidney regularly assists companies in the healthcare and life sciences industry on non-contentious and contentious IP matters, and various healthcare regulatory issues, including product approval, market access, labelling, advertising and promotion, interactions with consumers and healthcare professionals, pricing and reimbursement. He also has broad experience, including in the Australian Federal Courts, State Courts and Tribunals in matters concerning patents, trade marks, copyright, breach of confidence, trade practices and breach of contract.
Prior to obtaining his legal qualifications, Sidney practised as a pharmacist in Australia in both hospital and community settings. He draws upon this practical experience to help clients navigate complex regulatory issues in the healthcare space.
Notes
*Competitor Exclusion – ACC Australia Partner’s may request that representative/s of a competitor organisation/s registered for the event be excluded, and ACC Australia reserves the right to make the final decision as to whether a registration is rejected. As a guide, a competitor organisation could be defined as a rival organisation of similar size to the host Corporate Partner, with an established practice, product or service in the area being showcased by the Corporate Partner’s at the event. Please provide a brief statement as to why you have deemed an organisation to be a competitor, in support of any request to ACC Australia to reject a registration.
CLE
Sponsored By
